These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 6723838

  • 1. Effects of inhaled N-acetylcysteine in combination with terbutaline.
    Stiksa G, Nemcek K, Melin S.
    Eur J Respir Dis; 1984 May; 65(4):278-82. PubMed ID: 6723838
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM, Phillips C, Wooler PA.
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [Abstract] [Full Text] [Related]

  • 4. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A, Grieco A, Vibelli C.
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [Abstract] [Full Text] [Related]

  • 5. [Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study].
    Vestbo J, Sørensen T, Lange P, Brix A, Torre P, Viskum K.
    Ugeskr Laeger; 2000 Jan 24; 162(4):493-7. PubMed ID: 10697447
    [Abstract] [Full Text] [Related]

  • 6. N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test.
    Ghanei M, Shohrati M, Jafari M, Ghaderi S, Alaeddini F, Aslani J.
    Basic Clin Pharmacol Toxicol; 2008 Nov 24; 103(5):428-32. PubMed ID: 18801028
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The cardiorespiratory effects of oral terbutaline and an ephedrine-theophylline-phenobarbital combination: comparison in patients with chronic obstructive ventilatory disorders.
    Cohen BM.
    Ann Allergy; 1978 Apr 24; 40(4):233-9. PubMed ID: 345887
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Domiciliary nebulized terbutaline in severe chronic airways obstruction.
    Hansen NC, May O.
    Eur Respir J; 1990 Apr 24; 3(4):463-4. PubMed ID: 2365041
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of different extension-actuator tubes on the bronchodilation effect of a terbutaline sulfate aerosol.
    Lulling J, Delwiche JP, Hidinger KG, Prignot J.
    Eur J Respir Dis; 1983 Jan 24; 64(1):33-7. PubMed ID: 6825747
    [Abstract] [Full Text] [Related]

  • 16. Bronchodilator treatment for partially reversible chronic obstructive airways disease.
    Tandon MK, Kailis SG.
    Thorax; 1991 Apr 24; 46(4):248-51. PubMed ID: 2038732
    [Abstract] [Full Text] [Related]

  • 17. The effect of inhaled terbutaline on FEV1, FVC, dyspnoea and walking distance in patients with chronic obstructive lung disease.
    Leitch AG.
    Respir Med; 1992 Nov 24; 86(6):527-8. PubMed ID: 1470713
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
    Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR.
    Respir Med; 2000 Aug 24; 94(8):767-71. PubMed ID: 10955752
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.